TY - JOUR
T1 - Toward Multidimensional Message Tailoring to Address COVID-19 and Influenza Vaccine-Hesitancy
T2 - A Latent Profile Analysis Approach
AU - Shen, Lijiang
N1 - Publisher Copyright:
© 2024 Taylor & Francis Group, LLC.
PY - 2024
Y1 - 2024
N2 - Vaccines remain the best strategy as the COVID-19 pandemic enters into later stages and governments begin to shed pandemic-control measures. Vaccine hesitancy continues to be a major obstacle in efforts to end the pandemic. This study reports formative evaluation research that adopted a multidimensional approach using latent profile analysis to audience segmentation and message targeting. Within the framework of the integrated behavioral model, data were collected from a US national survey to explore the dimensions in which vaccine-confident vs. -hesitant individuals differed significantly across the topics of COVID-19 and influenza. Latent profile analyses were performed to identify subgroups and establish measurement invariance between COVID-19 and influenza vaccines. Matching message strategies were proposed for the distinctive characteristics of the subgroups for both topics and to be tested in future research.
AB - Vaccines remain the best strategy as the COVID-19 pandemic enters into later stages and governments begin to shed pandemic-control measures. Vaccine hesitancy continues to be a major obstacle in efforts to end the pandemic. This study reports formative evaluation research that adopted a multidimensional approach using latent profile analysis to audience segmentation and message targeting. Within the framework of the integrated behavioral model, data were collected from a US national survey to explore the dimensions in which vaccine-confident vs. -hesitant individuals differed significantly across the topics of COVID-19 and influenza. Latent profile analyses were performed to identify subgroups and establish measurement invariance between COVID-19 and influenza vaccines. Matching message strategies were proposed for the distinctive characteristics of the subgroups for both topics and to be tested in future research.
UR - http://www.scopus.com/inward/record.url?scp=85186542617&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85186542617&partnerID=8YFLogxK
U2 - 10.1080/10410236.2024.2321763
DO - 10.1080/10410236.2024.2321763
M3 - Article
C2 - 38408900
AN - SCOPUS:85186542617
SN - 1041-0236
JO - Health Communication
JF - Health Communication
ER -